Detection of intrauterine illicit drug exposure by newborn drug testing

Clinical Chemistry

Volumn 43, Issue 1, 1997, Pages 235-242

  Kwong, Tai C ^a   Ryan, Rita M ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

drug screening; gas chromatography mass spectrometry; hair analysis; immunoassays; meconium; urine testing

Indexed keywords

ILLICIT DRUG;

AMNION FLUID ANALYSIS; CONFERENCE PAPER; DRUG DEPENDENCE; DRUG SCREENING; GAS CHROMATOGRAPHY; HUMAN; MASS SPECTROMETRY; MATERNAL DISEASE; MECONIUM; PRENATAL DRUG EXPOSURE; STOMACH SUCTION; URINALYSIS;

EID: 0031021205     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/43.1.235     Document Type: Conference Paper

References (85)

1. Young SL, Vosper HJ, Phillips SA. Cocaine: its effects on maternal and child health. Pharmacotherapy 1992;12:2-17.
2. Bell GL, Lau K. Perinatal and neonatal issues of substance abuse. Pediatr Clin North Am 1995;42:261-81.
3. Chasnoff IJ. Cocaine, pregnancy and the neonate. Women Health 1989;15:23-5.
4. Chasnoff IJ, Griffith DR. Cocaine: clinical studies of pregnancy and the newborn. Ann N Y Acad Sci 1989;562:260-6.
5. Cohen HR, Green JR, Crombleholme WR. Peripartum cocaine use: estimating risk of adverse pregnancy outcome. Int J Gynaecol Obstet 1991;35:51-4.
6. Gillogley KM, Evans AT, Hansen RL, Samuels SJ, Batra KK. The perinatal impact of cocaine, amphetamine, and opiate use detected by universal intrapartum screening. Am J Obstet Gynecol 1990;163:1535-42.
7. Little BB, Snell LM, Klein VR, Gilstrap LC III. Cocaine abuse during pregnancy: maternal and fetal implications. Obstet Gynecol 1989; 73:157-60.
8. Ney JA, Dooley SL, Keith LG, Chasnoff IJ, Socol ML. The prevalence of substance abuse in patients with suspected preterm labor. Am J Obstet Gynecol 1990;162:1562-7.
9. Oro AS, Dixon SD. Perinatal cocaine and methamphetamine exposure: maternal and neonatal correlates. J Pediatr 1987;111: 571-8.
10. Chasnoff IJ, Bussey ME, Savich R, Stack CM. Perinatal cerebral infarction and maternal cocaine use. J Pediatr 1986;108:456-9.
11. Chavez GF, Mulinare J, Cordera J. Maternal cocaine use during early pregnancy as a risk factor for congenital urogenital anomalies. JAMA 1989;262:795-8.
12. Czyrko C, Del Pin CA, O'Neill JA, Peckham GJ, Ross AJ III. Maternal cocaine abuse and necrotizing enterocolitis: outcome and survival. J Pediatr Surg 1991;26:414-21.
13. Dixon SD, Bejar R. Echoencephalographic findings in neonates associated with maternal cocaine and methamphetamine use: incidence and clinical correlates. J Pediatr 1989;115:770-8.
14. Downing GJ, Horner SR, Kilbride HW. Characteristics of perinatal cocaine-exposed infants with necrotizing enterocolitis. Am J Dis Child 1991;145:26-7.
15. Fulroth R, Phillips B, Duranc DJ. Perinatal outcomes of infants exposed to cocaine and/or heroin in utero. Am J Dis Child 1989;143:905-10.
16. Greenfield SP, Rutigliano E, Steinhardt G, Elder JS. Genitourinary tract malformations and maternal cocaine abuse. Urology 1991; 307:455-9.
17. Handler A, Kistin N, Davis F, Ferre C. Cocaine use during pregnancy: perinatal outcomes. Am J Epidemiol 1991;133:818-25.
18. Kelley SJ, Walsh JH, Thompson K. Birth outcomes, health problems, and neglect with prenatal exposure to cocaine. Pediatr Nurs 1991;17:130-6.
19. Lipshultz SE, Frassjca JJ, Orav EJ. Cardiovascular abnormalities in infants prenatally exposed to cocaine. J Pediatr 1991;118:44-51.
20. Sehgal S, Ewing C, Waring P, Findlay R, Bean X, Taeusch W. Morbidity of low-birthweight infants with intrauterine cocaine exposure. J Natl Med Assoc 1993;85:20-4.
21. Zuckerman B, Frank D, Hingson R, Amaro H, Levenson S, Kayne H, et al. Effects of maternal marijuana and cocaine use on fetal growth. N Engl J Med 1989;320:762-8.
22. Lopez SL,Taeusch HW, Findlay RD, Walther FJ. Time of onset of necrotizing enterocolitis in newborn infants with known prenatal cocaine exposure. Clin Pediatr (Phila) 1995;34:424-9.
23. Franck L, Vilardi J. Assessment and management of opioid withdrawal in ill neonates. Neonatal Netw 1995:14:39-48.
24. Finnegan LP, Kaltenbach K. Neonatal abstinence syndrome. In: Hoekelman RA, ed. Primary pediatric care, 3rd ed. St Louis: CV Mosby, 1996;1367-78.
25. Mastrogiannis DS, DeCavalas GO, Verma U, Tejani N. Perinatal outcome after recent cocaine usage. Obstet Gynecol 1990;76:8-11.
26. LeBlanc PE, Parekh AJ, Naso B, Glass L. Effects of intrauterine exposure to alkaloidal cocaine ('crack'). Am J Dis Child 1987;141: 937-8.
27. Dixon SD. Effects of transplacental exposure to cocaine and methamphetamine on the neonate. West J Med 1991;150:436-42.
28. Regan DO, Ehrlich SM, Rnnegan LP. Infants of drug addicts: at risk for child abuse, neglect and placement in foster care. Neurotoxicol Teratol 1987;9:315-9.
29. Jaudes PK, Ekwo E, Van Voorhis J. Association of drug abuse and child abuse. Child Abuse Negl 1995;19:1065-75.
30. Chasnoff IJ, Griffith DR, Freier C, Murray J. Cocaine/polydrug use in pregnancy: two year follow-up. Pediatrics 1992;89:284-9.
31. Schneider JW, Chasnoff IJ. Motor assessment of cocaine/polydrug exposed infants at age 4 months. Neurotoxicol Teratol 1992;14:97-101.
32. Singer L, Arendt R, Minnes S. Neurodevelopmental effects of cocaine. Clin Perinatol 1993;20:245-62.
33. Streissguth AP, Grant TM, Barr HM, Brown ZA, Martin JC, Maycock DE, et al. Cocaine and the use of alcohol and other drugs during pregnancy. Am J Obstet Gynecol 1991;164:1239-43.
34. Van Baar AL, Soepatmi S, Gunning WB, Akkerhuis GW. Development after prenatal exposure to cocaine, heroin and methadone. Acta Paediatr Suppl 1994;404:40-6.
35. Chasnoff I, Hunt CE, Kletter R, Kaplan D. Prenatal cocaine exposure is associated with respiratory pattern abnormalities. Am J Dis Child 1989;143:583-7.
36. Ward SL, Bautista D, Chan L, Derry M, Lisbin A, Durfee MJ, et al. Sudden infant death syndrome in infants of substance-abusing mothers. J Pediatr 1990;117:878-81.
37. Kandall SR, Gaines J, Habel L, Davidson G, Jessop D. Relationship of maternal substance abuse to subsequent sudden infant death syndrome in offspring. J Pediatr 1993;123:120-6.
38. Sylvestri JM, Long JM, Weese-Mayer DE, Barkov GA. Effect of prenatal cocaine on respiration, heart rate, and sudden infant death syndrome. Pediatr Pulmonol 1991:11:328-34.
39. Kharasch SJ, Glotzer D, Vinci R, Weitzman M, Sargent J. Unsuspected cocaine exposure in young children. Am J Dis Child 1991:145:204-6.
40. Mirchandani HG, Mirchandani IH, Hellman F, English-Rider R, Rosen S, Laposata EA. Passive inhalation of free-base cocaine ('crack'} smoke by infants. Arch Pathol Lab Med 1991;115: 494-8.
41. Rosenberg NM, Meert K, Marino D, Yee H, Kauffman RE. Occult cocaine and opiate exposure in children and associated physical findings. Pediatr Emerg Care 1995:11:167-9.
42. Frank DA, Zuckerman BS, Amaro H, Aboague K, Bauchner H, Cabrai H, et al. Cocaine use during pregnancy: prevalence and correlates. Pediatrics 1988:82:888-95.
43. Matera C, Warren WB, Moomjy M, Fink DJ, Fox HE. Prevalence of use of cocaine and other substances in an obstetric population. Am J Obstet Gynecol 1990:163:797-801.
44. Garcia DC, Romero A, Garcia GC, Ostrea EM. Gastric fluid analysis for determining gestational cocaine exposure. Pediatrics 1996; 98:291-3.
45. Committee on Substance Abuse. Drug-exposed infants. Pediatrics 1995:96:364-6.
46. Ryan RM, Wagner CL, Schultz JM, Varley J, DiPreta J, Sherer DM, et al. Meconium analysis improves identification of intrauterine cocaine exposed infants. J Pediatr 1994;125:435-40.
47. Ostrea EM Jr. Brady MJ, Parks PM, Asensio DC, Naluz A. Drug screening of meconium in infants of drug-dependent mothers: an alternative to urine testing. J Pediatr 1989;115:474-7.
48. Schutzman DL, Frankenfield-Chernicoff M, Clatterbaugh HE, Singer J. Incidence of intrauterine cocaine exposure in a suburban setting. Pediatrics 1991;88:825-7.
49. McCalla S, Minkoff HL, Feldman J, Delke I, Salwin M, Valencia G, Glass L. The biologic and social consequences of perinatal cocaine use in an inner-city population: results of an anonymous cross sectional study. Am J Obstet Gynecol 1991;164:625-30.
50. Chasnoff U, Landress HJ, Barrett ME. The prevalence of illicit-drug and alcohol use during pregnancy and discrepancies in mandatory reporting in Pinellas County, Rorida. N Engl J Med 1990;322: 1202-6.
51. Vega WA, Kolody B, Hwang J, Moble A. Prevalence and magnitude of perinatal substance exposures in California. N Engl J Med 1993:329:850-4.
52. Webber MP, Lambert G, Bateman DA, Hauser WA. Maternal risk factors for congenital syphilis: a case-control study. Am J Epidemiol 1993:137:415-22.
53. Halstead AC, Godolphin W, Lockitch G, Segal S. Timing of specimen collection is crucial in urine screening of drug dependent mothers and newborns. Clin Biochem 1988:21:59-61.
54. Mandatory guidelines for federal workplace drug testing programs. Fed Regist 1988:53:11979-89.
55. Hicks JM, Morales A, Soldin SJ. Drugs of abuse in a pediatrie outpatient population [Letter]. Clin Chem 1990:36:1256-7.
56. Casanova OQ, Lombardero N, Behnke M, Eyler FD, Conlon M, Bertholf RL. Detection of cocaine exposure in the neonate. Arch Pathol Lab Med 1994:118:988-93.
57. Lewis D, Moore C, Leikin JB, Kechavarz L. Multiple birth concordance of street drug assays of meconium analysis. Vet Hum Toxicol 1995:37:318-9.
58. Ostrea EM, Brady M, Cause S, Raymundo AL, Stevens M. Drug screening of newborns by meconium analysis: a large-scale, prospective, epidemiologic study. Pediatrics 1992:89:107-13.
59. Maynard EC, Amoruso LP, Oh W. Meconium for drug testing. Am J Dis Child 1991:145:650-2.
60. Callahan CM, Grant TM, Phipps P, Clark G, Novack AH, Streissguth AP, Raisys VA. Measurement of gestational cocaine exposure: sensitivity of infants' hair, meconium, and urine. J Pediatr 1992; 120:763-8.
61. Lewis DE, Moore CM, Leikin JB, Koller A. Meconium analysis for cocaine: a validation study and comparison with paired urine analysis. J Anal Toxicol 1995:19:148-50.
62. Bibb KW, Stewart DL, Walker JR, Cook VD. Drug screening in newborns and mothers using meconium samples, paired urine samples, and interviews. J Perinatol 1995:15:199-202.
63. Wingert WE, Feldman MS, Kim MH, Noble L, Hand I, Yoon JJ. A comparison of meconium, maternal urine and neonatal urine for detection of maternal drug use during pregnancy. J Forensic Sei 1994:39:150-8.
64. Gourley GR, Kreamer B, Arend R. Excremental studies in human neonates. Gastroenterology 1990;99:1705-9.
65. Verna A, Dhanireddy R. Time of first stool in extremely low birth weight (<1000 gm) infants. J Pediatr 1992:122:626-9.
66. Clark GD, Rosenzweig B, Raisys VA, Callahan CM, Grant TM, Streissguth AP. The analysis of cocaine and benzoylecgonine in meconium. J Anal Toxicol 1992:16:261-3.
67. Ostrea EM, Romero A, Yee H. Adaptation of meconium drug test for mass screening. J Pediatr 1993:122:152-4.
68. Murphey U, Olsen G, Konkol RJ. Quantitation of benzoylnorecgonine and other cocaine metabolites in meconium by high-performance liquid chromatography. J Chromatogr 1993:613:330-5.
69. Lombardero N, Casanova O, Behnke M, Eyler FD, Bertholf RL. Measurement of cocaine and metabolites in urine, meconium, and diapers by gas chromatography/mass spectrometry. Ann Clin Lab Sei 1993;23:385-94.
70. Abusada GM, Abukhalaf IK, Alford DD, et al. Solid-phase extraction and GC/MS quantitation of cocaine, ecgonine rrtethyl ester, benzoylecgonine, and cocaethylene from meconium, whole blood, and plasma. J Anal Toxicol 1993:17:353-8.
71. Moeller MR, Fey P. Simultaneous determination of drugs of abuse (opiates, cocaine and amphetamine) in human hair by GC/MS and its application to a methadone treatment program. Forensic Sei Int 1993:63:185-206.
72. Baumartner WA, Hill VA, Blahd WH. Hair analysis for drugs of abuse. J Forensic Sei 1989;34:1433-53.
73. Blank DL, Kidwell DA. Decontamination procedures for drugs of abuse in hair: are they sufficient? Forensic Sei Int 1995;70:1338.
74. Wang WL, Cone EJ. Testing human hair for drugs of abuse. IV. Environmental cocaine contamination and washing effects. Forensic Sei Int 1995:70:39-51.
75. Koren G, Klein J, Forman R, Graham K. Hair analysis of cocaine: differentiation between systemic exposure and external contamination. J Clin Pharmacol 1992:32:671-5.
76. Koren G. Measurement of drugs in neonatal hair; a window to fetal exposure. Forensic Sei Int 1995;70:77-82.
77. MoellerMR, Fey P. Simultaneous determination of drugs of abuse (opiates, cocaine and amphetamine) in human hair by GC-MS and its application to a methadone treatment program. Forensic Sei Int 1993:63:185-206.
78. Staub C. Analytical procedures for determination of opiates in hair: a review. Forensic Sei Int 1995:70:111-23.
79. Brewer C. Hair analysis as a tool for monitoring and managing patients on methadone maintenance. Forensic Sei Int 1993;63: 277-83.
80. Graham K, Koren G, Klein J, Schneiderman J, Greenwald M. Determination of gestational cocaine exposure by hair analysis. JAMA 1989:262:3328-30.
81. Selavka CM, Rieders F. The determination of cocaine in hair: a review. Forensic Sei Int 1995;70:155-64.
82. Klein J, Forman R, Eliopoulos C, Koren G. A method for simultaneous measurement of cocaine and nicotine in neonatal hair. Ther Drug Monit 1994:16:67-70.
83. Kidwell DA. Analysis of phehcyclidine and cocaine in human hair by tandem mass spectrometry. J Forensic Sei 1993:38:272-84.
84. Jain L, Meyer W, Moore C, Tebbett I, Gauthier D, Vidyasagar D. Detection of fetal cocaine exposure by analysis of amniotic fluid. Obstet Gynecol 1993:81:787-90.
85. ElSohly MA, Jones AB. Morphine and codeine in biological fluids: approaches to source differentiation. Forensic Sei Rev 1989;!: 14-22.